PMID: 2496427Jan 1, 1989Paper

Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats

Psychopharmacology
C T DourishS D Iversen

Abstract

The effects of nine central 5-HT antagonists on food intake in free feeding male rats were examined. The 5-HT2 antagonists ritanserin and ketanserin and the selective 5-HT3 antagonists ICS 205-930 and MDL 72222 had no effect on food intake. In contrast, the non-selective 5-HT antagonists metergoline, methiothepin, mesulergine, mianserin and methysergide (all of which have high affinity for various 5-HT1 receptor subtypes), dose-dependently increased food intake during a 4-h daytime test. Furthermore, metergoline dose dependently increased food intake over a 24-h period. Surprisingly, mesulergine decreased food intake over a 24-h period at the same doses that increased daytime food intake. This may indicate that the increase in daytime feeding produced by mesulergine is a non-specific response. Although the antagonists used have varying degrees of selectivity for 5-HT receptor subtypes, the pattern of results suggests that postsynaptic 5-HT1 receptors (possibly of the 5-HT1C type) play an important role in the control of feeding in rats.

References

Jun 12, 1978·Annals of the New York Academy of Sciences·B G HoebelC Norelli
Jun 12, 1978·Annals of the New York Academy of Sciences·D V Coscina
Nov 24, 1977·Psychopharmacology·B V ClineschmidtJ C McGuffin
Aug 1, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·R SamaninS Garattini
Dec 11, 1978·Life Sciences·P F SpanoM Trabucchi
Jan 1, 1975·Psychopharmacologia·T Silverstone, D Schuyler
Jan 1, 1987·Pharmacology & Therapeutics·M F Sugrue
Jun 1, 1987·British Journal of Pharmacology·B CostallM B Tyers
Jun 10, 1988·European Journal of Pharmacology·P H HutsonG Curzon
Feb 1, 1987·Pharmacology, Biochemistry, and Behavior·M Massi, S Marini
Jan 12, 1988·European Journal of Pharmacology·G HewsonJ Hughes
May 1, 1988·British Journal of Pharmacology·G A Kennett, G Curzon
Jan 1, 1986·Progress in Neurobiology·N E Rowland, J Carlton
Sep 23, 1987·European Journal of Pharmacology·G A KennettG Curzon
Nov 1, 1986·Brain Research Bulletin·G Shor-PosnerS F Leibowitz
Jan 1, 1981·British Journal of Clinical Pharmacology·R J SimpsonB Tiplady
May 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·J R Fozard

❮ Previous
Next ❯

Citations

Jan 1, 1989·Psychopharmacology·J C Neill, S J Cooper
Jan 1, 1995·Psychopharmacology·D N Velázquez MartínezJ E Villarreal
Jan 1, 1992·Psychopharmacology·M D Lee, P G Clifton
Jan 1, 1990·Psychopharmacology·R ShuklaR H Rech
Jan 17, 2007·Psychopharmacology·Karen K SzumlinskiM Scott Bowers
Apr 26, 2013·The Journal of Physiological Sciences : JPS·Morteza ZendehdelShahin Hassanpour
Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·I W Beczkowska, R J Bodnar
Aug 1, 1992·Pharmacology, Biochemistry, and Behavior·I W BeczkowskaR J Bodnar
Aug 1, 1992·Pharmacology, Biochemistry, and Behavior·J E KochR J Bodnar
May 1, 1993·Pharmacology, Biochemistry, and Behavior·S F LeibowitzG F Weiss
Oct 1, 1993·Pharmacology, Biochemistry, and Behavior·C L Lawton, J E Blundell
Oct 1, 1993·Pharmacology, Biochemistry, and Behavior·P J Fletcher, D V Coscina
Feb 1, 1994·Pharmacology, Biochemistry, and Behavior·G A HigginsE M Sellers
May 1, 1994·Pharmacology, Biochemistry, and Behavior·A K IslamR J Bodnar
May 1, 1990·Trends in Pharmacological Sciences·G Curzon, G A Kennett
Jan 1, 1996·Behavioural Brain Research·K J Simansky
Jan 1, 1991·General Pharmacology·M R ZarrindastT Hosseini-Nia
May 14, 2005·Neuroscience and Biobehavioral Reviews·Stephanie C Dulawa, Rene Hen
Nov 10, 1998·Biological Psychiatry·S F Leibowitz, J T Alexander
Nov 14, 2000·Brain Research·D V CoscinaB M King
Apr 1, 1997·Physiology & Behavior·K InoueS Yamagami
Mar 27, 2001·Pharmacology, Biochemistry, and Behavior·B J Hrupka, W Langhans
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·Katherine N HewittPeter G Clifton
Sep 2, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·G GiannakopoulosC Couvaris
Jan 1, 1997·Brain Research Bulletin·S M SteffensJ Marino-Neto
Apr 1, 1997·Neuropharmacology·G A KennettT P Blackburn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.